Portal de Periódicos da CAPES

The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

2018; Oxford University Press; Volume: 218; Issue: 12 Linguagem: Inglês

10.1093/infdis/jiy479

1537-6613

Golnaz Namazi, Jesse Fajnzylber, Evgenia Aga, Ronald J. Bosch, Edward P. Acosta, Radwa Sharaf, Wendy Hartogensis, Jeffrey M. Jacobson, Elizabeth Connick, Paul A. Volberding, Daniel J. Skiest, David M. Margolis, Michael C. Sneller, Susan J. Little, Sara Gianella, Davey M. Smith, Daniel R. Kuritzkes, Roy M. Gulick, John W. Mellors, Vikram Mehraj, Rajesh T. Gandhi, Ronald T. Mitsuyasu, Robert T. Schooley, Keith Henry, Pablo Tebas, Steven G. Deeks, Tae‐Wook Chun, Ann C. Collier, Jean‐Pierre Routy, Frederick Hecht, Bruce D. Walker, Jonathan Z. Li,

HIV/AIDS drug development and treatment

HIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART), but maintain HIV suppression after treatment interruption. The frequency of posttreatment control and posttreatment interruption viral dynamics have not been well characterized.